| 1 |
Lin C, Huang S, Tzou S, Yin C, Chen J, Chen Y, Chang S. Tendon Disorders in Chronic Liver Disease: A Retrospective Cohort Study in Taiwan. IJERPH 2023;20:4983. [DOI: 10.3390/ijerph20064983] [Reference Citation Analysis]
|
| 2 |
Iacopetta D, Ceramella J, Baldino N, Sinicropi MS, Catalano A. Targeting Breast Cancer: An Overlook on Current Strategies. Int J Mol Sci 2023;24. [PMID: 36835056 DOI: 10.3390/ijms24043643] [Reference Citation Analysis]
|
| 3 |
Joyce E, Carr G, Wang S, Brummett CM, Kidwell KM, Henry NL. Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients. Breast Cancer Res Treat 2023;197:397-404. [PMID: 36371776 DOI: 10.1007/s10549-022-06806-x] [Reference Citation Analysis]
|
| 4 |
Bae K, Lamoury G, Carroll S, Morgia M, Lim S, Baron-Hay S, Shin IS, Park SJ, Oh B. Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: A systematic review with network meta-analysis. Crit Rev Oncol Hematol 2023;181:103898. [PMID: 36535489 DOI: 10.1016/j.critrevonc.2022.103898] [Reference Citation Analysis]
|
| 5 |
Haenen V, Dams L, Meeus M, De Groef A. Altered somatosensory functioning and mechanism‐based classification in breast cancer patients with persistent pain. The Anatomical Record 2022. [DOI: 10.1002/ar.25121] [Reference Citation Analysis]
|
| 6 |
Wagner MA, Koleck TA, Conway A, Bender CM, Conley YP. DNA Repair/Oxidative Stress Genes and Pain in Cancer Survivors on Aromatase Inhibitors.. [DOI: 10.21203/rs.3.rs-2219362/v1] [Reference Citation Analysis]
|
| 7 |
Joyce E, Carr G, Wang S, Brummett CM, Kidwell KM, Henry NL. Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients.. [DOI: 10.21203/rs.3.rs-2110059/v1] [Reference Citation Analysis]
|
| 8 |
Bowman S, Lu H. Myopathies inflammatoires induites par des inhibiteurs de l’aromatase : 3 cas. Revue du Rhumatisme 2022;89:517-520. [DOI: 10.1016/j.rhum.2022.07.007] [Reference Citation Analysis]
|
| 9 |
Li Z, Liu Y, Li Y, Shang Y, Du K, Ji X, Han H, Zhang J. Full Compliance of Adjuvant Endocrine Therapy Is Associated with Higher Disease-Free Survival in Hormone Receptor-Positive and HER2-Negative Chinese Breast Cancer Patients with First Tumor Recurrence. Asian Pac J Cancer Prev 2022;23:3413-20. [PMID: 36308366 DOI: 10.31557/APJCP.2022.23.10.3413] [Reference Citation Analysis]
|
| 10 |
Pisarro M, Conti F. Salute ossea in corso di trattamento adiuvante anti-ormonale nella patologia oncologica: rischio fratturativo e temporizzazione della terapia. L'Endocrinologo 2022;23:386-393. [DOI: 10.1007/s40619-022-01132-2] [Reference Citation Analysis]
|
| 11 |
Boszkiewicz K, Piwowar A, Petryszyn P. Aromatase Inhibitors and Risk of Metabolic and Cardiovascular Adverse Effects in Breast Cancer Patients-A Systematic Review and Meta-Analysis. J Clin Med 2022;11:3133. [PMID: 35683517 DOI: 10.3390/jcm11113133] [Reference Citation Analysis]
|
| 12 |
Poltronieri TS, Pérsico RS, Falcetta FS, Viana LV. Changes in Body Adiposity in Women Undergoing Breast Cancer Treatment: A Scoping Review. Nutrition and Cancer. [DOI: 10.1080/01635581.2022.2081341] [Reference Citation Analysis]
|
| 13 |
Botelho LOD, Sañudo A, Facina G, Wagner GA. Adesão à Terapia Hormonal Adjuvante com Tamoxifeno e Anastrozol utilizando ARMS-12 e MMAS-4. Rev Bras Cancerol 2022;68. [DOI: 10.32635/2176-9745.rbc.2022v68n2.1960] [Reference Citation Analysis]
|
| 14 |
Grigorian N, Baumrucker SJ. Aromatase inhibitor–associated musculoskeletal pain: An overview of pathophysiology and treatment modalities. SAGE Open Medicine 2022;10:205031212210787. [DOI: 10.1177/20503121221078722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Abel MK, Morgan T, Othieno SA, Angeles A, Goldman M. Gynecological Management of the Breast Cancer Survivor. Best Practice & Research Clinical Obstetrics & Gynaecology 2022. [DOI: 10.1016/j.bpobgyn.2022.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
晏 婷. Research Progress on Aromatase Inhibitors Causing Arthralgia in Early Breast Cancer. ACM 2022;12:5024-5031. [DOI: 10.12677/acm.2022.126729] [Reference Citation Analysis]
|
| 17 |
Zhu XY, Li Z, Chen C, Feng RL, Cheng BR, Liu RY, Wang RT, Xu L, Wang Y, Tao X, Zhao P. Physical Therapies for Psychosomatic Symptoms and Quality of Life Induced by Aromatase Inhibitors in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:745280. [PMID: 34868943 DOI: 10.3389/fonc.2021.745280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Azcoitia I, Mendez P, Garcia-segura LM. Aromatase in the Human Brain. Androgens: Clinical Research and Therapeutics 2021;2:189-202. [DOI: 10.1089/andro.2021.0007] [Reference Citation Analysis]
|
| 19 |
Bowman S, Lu H. Aromatase inhibitor-induced inflammatory myopathies: A case series. Joint Bone Spine 2021;89:105308. [PMID: 34774793 DOI: 10.1016/j.jbspin.2021.105308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 20 |
Singh R, Adhya P, Sharma SS. Redox-sensitive TRP channels: a promising pharmacological target in chemotherapy-induced peripheral neuropathy. Expert Opin Ther Targets 2021;25:529-45. [PMID: 34289785 DOI: 10.1080/14728222.2021.1956464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 21 |
Melillo N, Landriscina M, Trotta A, Sciacca S, Cantatore FP. Sjögren syndrome diagnosis in a cohort of patients with breast cancer: a single-center experience. Beyond Rheumatol 2021;3. [DOI: 10.4081/br.2021.67] [Reference Citation Analysis]
|
| 22 |
Giampietro L, Gallorini M, Gambacorta N, Ammazzalorso A, De Filippis B, Della Valle A, Fantacuzzi M, Maccallini C, Mollica A, Cataldi A, Nicolotti O, Amoroso R. Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors. Eur J Med Chem 2021;224:113737. [PMID: 34365129 DOI: 10.1016/j.ejmech.2021.113737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Oza S. Aromatase Inhibitor-induced Musculoskeletal Syndrome: a Review of Rehabilitation Interventions. Curr Phys Med Rehabil Rep 2021;9:119-26. [DOI: 10.1007/s40141-021-00318-3] [Reference Citation Analysis]
|
| 24 |
Hyder T, Marino CC, Ahmad S, Nasrazadani A, Brufsky AM. Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management. Front Endocrinol (Lausanne) 2021;12:713700. [PMID: 34385978 DOI: 10.3389/fendo.2021.713700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Shin J, Harris C, Oppegaard K, Kober KM, Paul SM, Cooper BA, Hammer M, Conley Y, Levine JD, Miaskowski C. Worst Pain Severity Profiles of Oncology Patients Are Associated With Significant Stress and Multiple Co-Occurring Symptoms. J Pain 2021:S1526-5900(21)00289-3. [PMID: 34298161 DOI: 10.1016/j.jpain.2021.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 26 |
Gao Y, Yang K, Shi S, Wang J, Zhang J, Tian J. Tamoxifen and aromatase inhibitors for relapse of tubo-ovarian high-grade serous cancer. Cochrane Database of Systematic Reviews 2021;2022. [DOI: 10.1002/14651858.cd014757] [Reference Citation Analysis]
|
| 27 |
Xu XL, Deng SL, Lian ZX, Yu K. Estrogen Receptors in Polycystic Ovary Syndrome. Cells 2021;10:459. [PMID: 33669960 DOI: 10.3390/cells10020459] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
